Syros Pharmaceuticals, Inc (SYRS) insider trading

Every open-market stock purchase and sale by Syros Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

No open-market insider trades in the last 12 months.
Last insider buy: Jason Haas (CFO), $76K, 2 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent SYRS insider trades

No open-market trades in the last 12 months.

Get free alerts when an insider at Syros Pharmaceuticals, Inc files a new trade →